What is the current market size?

The joint pain injections market size was valued at USD 1.2 billion in 2023, driven by rising arthritis prevalence and advanced treatment options.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by aging populations and non-surgical treatment adoption.

What are the key growth drivers?

Key drivers include chronic musculoskeletal disease prevalence, technological advancements in minimally invasive therapies, and increasing healthcare spending.

What challenges does the market face?

High treatment costs, regulatory scrutiny, and potential side effects from corticosteroid use hinder market growth, especially in price-sensitive regions.

Which regions lead the market?

North America dominates, followed by Europe and Asia-Pacific, with the U.S. and Germany leading due to advanced healthcare infrastructure.

Who are the top companies?

Leaders include OrthoPediatrics Corp, Medicom, and Cigna, alongside Smith & Nephew and Stryker, which focus on R&D and strategic partnerships.

What future opportunities exist?

Emerging opportunities lie in biologics, regenerative therapies, and expansion into underserved markets like Latin America and Southeast Asia.

How does technology impact this market?

AI-driven diagnostics and robotic injection systems enhance precision, while 3D imaging improves treatment outcomes and patient satisfaction.

What is the regulatory landscape?

Strict FDA and EMA guidelines govern safety and efficacy, with evolving standards for biologics and biosimilars shaping market entry requirements.

joint pain injections Market: Opportunity by 2034 | In-Depth Report

joint pain injections by Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Types (Corticosteroid Injections, Hyaluronic Acid Injections, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

joint pain injections Market Size | CAGR 18.5 Forecast 2033

joint pain injections Market: Opportunity by 2034 | In-Depth Report

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

joint pain injections Market Overview

The joint pain injections market encompasses therapeutic interventions such as corticosteroids, hyaluronic acid, and platelet-rich plasma (PRP) used to alleviate inflammation, regenerate cartilage, and manage chronic conditions like osteoarthritis and rheumatoid arthritis. As a critical segment of orthopedic care, this industry addresses the rising global burden of musculoskeletal disorders, offering non-surgical alternatives with growing patient adoption. The joint pain injections market size is projected to exceed $4.1 billion by 2033, reflecting a CAGR of 6.8% from 2026–2033, driven by aging demographics, rising obesity rates, and advancements in regenerative medicine. The growth outlook remains robust, with industry expansion fueled by biologics innovation and expanding coverage under public and private healthcare systems.

Key forces shaping the joint pain injections market forecast include the shift toward minimally invasive therapies, regulatory approvals for novel drug delivery systems (e.g., extended-release corticosteroids), and increasing consumer preference for outpatient procedures. North America dominates the market (accounting for ~42% of global revenue in 2026) due to high healthcare spending and advanced diagnostic infrastructure, while the Asia-Pacific region is the fastest-growing market, driven by urbanization, rising disposable incomes, and government initiatives to expand orthopedic care access. Strategic collaborations between biopharma firms and clinics, along with pipeline developments in stem cell-based treatments, are intensifying competitive dynamics, positioning the industry for transformative growth.

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	5.60 billion
Revenue forecast in 2033	21.77 billion
Growth rate	CAGR of 18.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Allergan; Pfizer; Sanofi; Anika Therapeutics; Ferring; Bioventus; Flexion Therapeutics; Zimmer Biomet Holdings; SEIKAGAKU CORPORATION; Chugai Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Aging populations and rising arthritis prevalence are fueling demand for joint pain injections market solutions, as degenerative joint diseases become more common in mature markets like North America and Europe.

Advancements in biologics and regenerative therapies, such as cell-based treatments and hyaluronic acid innovations, are expanding treatment options, driving joint pain injections market size expansion.

Restraints2 items

High treatment costs and limited insurance coverage for advanced therapies hinder accessibility, particularly in low- and middle-income countries, restraining joint pain injections market penetration.

Regulatory scrutiny of long-term safety data for novel injectables delays product approvals, slowing market entry of next-generation solutions.

Opportunities2 items

Personalized medicine trends present opportunities for tailored joint pain injections, leveraging biomarkers to optimize patient outcomes and justify premium pricing.

Emerging markets in Asia-Pacific and Latin America offer untapped growth potential as rising disposable incomes and medical tourism drive demand for joint pain injections market growth forecast.

Challenges2 items

Competition from over-the-counter analgesics and non-pharmaceutical interventions, such as physical therapy, threatens market share of specialized injectable solutions.

Supply chain disruptions for raw materials in biologics production, exacerbated by geopolitical tensions, risk product shortages and price volatility.

Market Segmentation

Loading chart…

In the joint pain injections segmentation, Application is a critical axis, with Arthritis Management dominating the market due to the high prevalence of osteoarthritis and rheumatoid arthritis. This segment accounts for ~45% of the market, driven by demand for corticosteroid and hyaluronic acid injections to alleviate chronic joint pain. Post-Surgical Rehabilitation constitutes ~30%, reflecting the role of injections in accelerating recovery after orthopedic procedures. Sports Injuries represent ~25%, fueled by rising participation in athletic activities and the need for rapid, non-surgical interventions. These applications collectively define the market’s growth trajectory, with arthritis management remaining the largest contributor due to its chronic and widespread nature.

The Types segment within joint pain injections is defined by Corticosteroids, Hyaluronic Acid, and Platelet-Rich Plasma (PRP). Corticosteroids (40% of the market) remain the most widely used due to their rapid anti-inflammatory effects and cost-effectiveness. Hyaluronic Acid (35%) dominates osteoarthritis treatment, particularly in knee joints, owing to its viscoelastic properties. PRP (25%) is a growth area, with subtypes such as Leukocyte-Rich PRP and Leukocyte-Poor PRP addressing distinct patient needs—e.g., inflammation modulation vs. tissue regeneration. This taxonomy underscores evolving trends toward regenerative medicine and personalized treatment protocols, diversifying the market’s value proposition.

joint pain injections Segmentation Breakdown8 items

Application

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Types

Corticosteroid Injections

Hyaluronic Acid Injections

Others

Regional Insights

Loading chart…

North America dominates the joint pain injections market with a 45% share, driven by high adoption rates of advanced therapies, robust healthcare infrastructure, and a growing aging population. Regulatory support for minimally invasive procedures and increasing investments in biologics bolster market growth. The region forecasts steady expansion due to rising prevalence of osteoarthritis and patient preference for non-surgical solutions.

Europe follows with a 25% share, shaped by strong reimbursement policies, a mature healthcare ecosystem, and high patient awareness. Demographic trends, including an aging population, accelerate demand. Cross-border collaborations among pharmaceutical firms and clinics further enhance treatment accessibility, supporting the joint pain injections market growth.

Asia Pacific is the fastest-growing region, projected to expand at a CAGR of 12% through 2030. Rising disposable incomes, urbanization, and government initiatives to improve healthcare access in countries like India and China are key drivers. However, infrastructure gaps in rural areas remain a challenge. Partnerships with global players are critical to scaling adoption.

Latin America (10% share) and Middle East & Africa (5% share) exhibit emerging potential. Latin America benefits from growing private healthcare investment and partnerships with international manufacturers, while the Middle East & Africa leverage increasing orthopedic awareness and infrastructure upgrades. Both regions require policy reforms to sustain joint pain injections market growth.

Competitive Landscape

The joint pain injections competitive landscape is moderately consolidated, with a mix of global pharmaceutical firms and regional medtech players. Global entities such as Allergan, Sanofi, and Pfizer dominate through diversified product portfolios and regulatory approvals, while regional firms like Zimmer Biomet and Chugai target niche markets with localized formulations. Key competitive levers include rapid product innovation (e.g., biologics and long-acting corticosteroids), strategic geographic expansion, and pricing differentiation. Regulatory compliance and clinical differentiation remain critical barriers to entry, particularly in mature markets with stringent approval frameworks.

Competitive strategies emphasize M&A activity, R&D investments, and partnership ecosystems to enhance market access. Differentiation hinges on proprietary technologies, such as Anika Therapeutics’ hyaluronic acid formulations or Bioventus’ regenerative medicine platforms. However, margin pressures from generic corticosteroid alternatives and reimbursement limitations in emerging markets pose persistent challenges. Players are increasingly adopting hybrid models—combining premium pricing with cost-optimized manufacturing—to balance innovation demands with affordability constraints.

Allergan: Premium pricing for aesthetic-focused joint injection products

Pfizer: R&D partnerships for biologic formulation development

Sanofi: Expansion into emerging markets via licensing agreements

Anika Therapeutics: Innovation pipeline targeting viscosupplementation

Ferring: OEM tie-ups for cost-efficient generic corticosteroid production

Zimmer Biomet: Regional expansion in Asia-Pacific via joint ventures

Key joint pain injections Companies10 items

Allergan

Pfizer

Sanofi

Anika Therapeutics

Ferring

Bioventus

Flexion Therapeutics

Zimmer Biomet Holdings

SEIKAGAKU CORPORATION

Chugai Pharmaceutical

Market Ecosystem

The joint pain injections ecosystem spans upstream raw materials and technology development, midstream manufacturing and formulation, and downstream delivery to healthcare providers and patients. Value is created through the integration of specialized biologics, pharmaceuticals, and medical devices, with participants collaborating to ensure treatment efficacy, regulatory compliance, and accessibility. Ecosystem dynamics are shaped by innovation in drug delivery systems, evolving clinical guidelines, and patient demand for minimally invasive therapies.

Raw material/component suppliers — provide biologics, steroids, and excipients for injection formulation

OEMs/Manufacturers — produce injectable drug products and pre-filled syringe devices

Technology providers — develop drug delivery systems and cryopreservation equipment

Distributors/Channel partners — manage logistics and supply chain distribution to healthcare facilities

Healthcare providers — administer injections and monitor patient outcomes in clinical settings

Regulators/Standards bodies — oversee product approvals and safety compliance

Service providers — offer training for injection techniques and post-treatment care

Control points reside with regulators, who dictate approval timelines, and technology providers, whose delivery systems influence therapeutic effectiveness. Dependency risks include raw material shortages and stringent clinical trial requirements. Healthcare providers face switching costs tied to training on proprietary injection devices, while interoperability is critical for integrating treatments into multi-modal pain management protocols. Regional variations emerge in regulatory frameworks and reimbursement policies, affecting market access and adoption rates.

Recent Industry Insights

The joint pain injections industry trends have witnessed significant momentum over the past 18 months, driven by innovation and strategic collaborations. Companies have prioritized expanding treatment options for osteoarthritis and rheumatoid arthritis, with a notable rise in partnerships between biotech firms and healthcare providers to streamline R&D. For instance, a leading orthopedic solutions company recently collaborated with a regenerative medicine startup to develop next-generation corticosteroid formulations with reduced side effects. Meanwhile, mergers & acquisitions activity has intensified, as seen in the acquisition of a specialty pharmaceutical firm by a global healthcare giant to bolster its portfolio of viscosupplementation therapies.

Product launches have dominated 2024, with several firms introducing AI-guided injection systems to enhance precision and patient outcomes. Regulatory bodies have also shifted focus toward safety, with the FDA issuing updated guidelines for post-market monitoring of long-acting joint injections. On the demand side, a growing preference for non-opioid pain management solutions has accelerated adoption, particularly in aging populations. Furthermore, $350M+ in venture funding has flowed into startups specializing in biodegradable polymer-based injectables, signaling strong investor confidence in the sector’s future.

Analyst Overview

The joint pain injections market remains highly attractive due to rising prevalence of osteoarthritis, rheumatoid arthritis, and an aging global population. Market attractiveness is further bolstered by advancements in biologics and targeted therapies. However, competitive intensity is escalating, with key players dominating through robust R&D pipelines while emerging firms focus on niche segments. The long-term outlook for the joint pain injections market outlook is optimistic, driven by untapped demand in emerging economies and growing patient preference for minimally invasive treatments. Innovation landscape activity is concentrated in drug delivery systems and personalized medicine, though regulatory hurdles may slow commercialization. Demand–supply balance faces regional disparities, with shortages in lower-income regions contrasting oversupply in mature markets. Key risk factors include pricing pressures, reimbursement challenges, and adverse event reporting impacting patient trust. Strategic partnerships and portfolio diversification will be critical for sustained growth.

Critical Insights for Decision-Makers3 items

Market dominance by top 5 players accounts for 45%+ of global revenue

Innovation in nanoparticle-based drug formulations could redefine treatment standards

Emerging markets present 20% CAGR+ potential by 2030

12 items

1. Executive Summary

2. joint pain injections Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global joint pain injections Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global joint pain injections Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global joint pain injections Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global joint pain injections Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global joint pain injections Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global joint pain injections Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global joint pain injections Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global joint pain injections Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global joint pain injections Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global joint pain injections Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global joint pain injections Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global joint pain injections Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global joint pain injections Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global joint pain injections Market Competition by Key Manufacturers

9.1. Global joint pain injections Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global joint pain injections: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Allergan

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Pfizer

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Sanofi

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Anika Therapeutics

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Ferring

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Bioventus

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Flexion Therapeutics

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Zimmer Biomet Holdings

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. SEIKAGAKU CORPORATION

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Chugai Pharmaceutical

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global joint pain injections Market

Figure 4: Global joint pain injections Market: Drivers

Figure 5: Global joint pain injections Market: Challenges

Figure 6: Global joint pain injections Market: Trends

Figure 7: Global joint pain injections Market: Opportunity

Figure 8: Global joint pain injections Market: Restraint

Figure 9: Global joint pain injections Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global joint pain injections Market Value (USD Million) By Region

Figure 19: Global joint pain injections Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global joint pain injections Market Value (USD Million) By Region

Figure 27: Global joint pain injections Market Share (%) By: Regions (2032)

Figure 28: Global joint pain injections Market Volume (K) By Region

Figure 29: Global joint pain injections Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global joint pain injections Market Value (USD Million) By Region

Figure 37: Global joint pain injections Market Share (%) By: Regions (2032)

Figure 38: Global joint pain injections Market Volume (K) By Region

Figure 39: Global joint pain injections Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global joint pain injections Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global joint pain injections Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global joint pain injections Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global joint pain injections Market Value (USD Million) By Region

Table 14: Global joint pain injections Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global joint pain injections Market Volume (K) By Region

Table 31: Global joint pain injections Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global joint pain injections Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global joint pain injections Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global joint pain injections Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Allergan Basic Information And Sales Area

Table 52: Allergan. Products Portfolio

Table 53: Pfizer Basic Information And Sales Area

Table 54: Pfizer. Products Portfolio

Table 55: Sanofi Basic Information And Sales Area

Table 56: Sanofi. Products Portfolio

Table 57: Anika Therapeutics Basic Information And Sales Area

Table 58: Anika Therapeutics. Products Portfolio

Table 59: Ferring Basic Information And Sales Area

Table 60: Ferring. Products Portfolio

Table 61: Bioventus Basic Information And Sales Area

Table 62: Bioventus. Products Portfolio

Table 63: Flexion Therapeutics Basic Information And Sales Area

Table 64: Flexion Therapeutics. Products Portfolio

Table 65: Zimmer Biomet Holdings Basic Information And Sales Area

Table 66: Zimmer Biomet Holdings. Products Portfolio

Table 67: SEIKAGAKU CORPORATION Basic Information And Sales Area

Table 68: SEIKAGAKU CORPORATION. Products Portfolio

Table 69: Chugai Pharmaceutical Basic Information And Sales Area

Table 70: Chugai Pharmaceutical. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global joint pain injections Market Value (USD Million) By Region

Table 80: Global joint pain injections Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global joint pain injections Market Volume (K) By Region

Table 97: Global joint pain injections Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

joint pain injections Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	5.60 billion
Revenue forecast in 2033	21.77 billion
Growth rate	CAGR of 18.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Allergan; Pfizer; Sanofi; Anika Therapeutics; Ferring; Bioventus; Flexion Therapeutics; Zimmer Biomet Holdings; SEIKAGAKU CORPORATION; Chugai Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options